










































Palliative care in chronic illness
Citation for published version:
Murray, SA, Boyd, K & Sheikh, A 2005, 'Palliative care in chronic illness: We need to move from prognostic
paralysis to active total care' BMJ, vol. 330, no. 7492, pp. 611-612. DOI: 10.1136/bmj.330.7492.611
Digital Object Identifier (DOI):
10.1136/bmj.330.7492.611
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:




Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 05. Apr. 2019
many years’ effort by health services in rural areas, only
5.4% of people with hypertension receive drug
treatment and only 0.9% have their blood pressure
effectively controlled.7 11
Research evidence on the biological efficacy of
these drugs is often universally generalisable. Guide-
lines are, however, value laden, have cost implications,
and are not universally applicable; thus those
developed for one population may not suit another. As
well as the thresholds for initiating treatment, factors
such as treatment targets, competing priorities for
drugs, diagnostic testing, and frequency of follow-up all
have cost implications. The treatment target is the level
of blood pressure or cholesterol to achieve through
treatment—the lower the target the more resources are
required to achieve it. China should probably consider
targets that differ from those for Western populations.
Locally tailored treatment guidelines could further
improve cost efficiency. For instance, antihypertensive
drugs might be given precedence in China, particularly
in the rural areas, over cholesterol lowering drugs
because they are cheaper and also reduce the
incidence of stroke. Stroke is common in China, and in
some areas it is the leading cause of death. Each year
1.3 million people have a first stroke, four times the
incidence of acute myocardial infarction.12
Given national differences in epidemiology, local
needs, and affordability, developing countries such as
China need to tailor their national policies for manag-
ing chronic conditions. If policies for other populations
are used, adapting, rather than simply adopting, will
bring greater benefits to patients.
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Palliative care in chronic illness
We need to move from prognostic paralysis to active total care
Health, social, and palliative care services arecontinuing to fail many people with progres-sive chronic illnesses in whom death may be
approaching, reflecting a failure to think proactively
and holistically about their care.1 Such people could,
however, readily be identified by clinicians asking
themselves, “Would I be surprised if my patient were to
die in the next 12 months?” For patients in whom the
answer is no, delivery of patient centred active
treatment and supportive care are needed.
Prognostic paralysis has been described, whereby
clinicians of patients with uncertain illness trajectories
prevaricate when considering end of life issues.2 For
example, one general practitioner graphically summa-
rised the feelings many experience in caring for people
with terminal heart failure: “You’re paddling down-
stream to Niagara.”Another felt reduced to clinical tasks:
“I feel impotent, merely a blood leech and monitor.”3
End stage chronic obstructive pulmonary disease is
another example where patients seldom receive holistic
care appropriate to their needs.4 Decision analysis in end
stage renal failure should include the option of palliative
care.5 Similarly, management of diabetes at the end of
life may need to be altered to reflect different, more
appropriate goals.6 To help overcome prognostic paraly-
sis, quality improvement teams in the United States sug-
gest that, rather than target patients who will die in the
next six months, we should focus on those who “reason-
ably might die.”7 In the United Kingdom at least, oppor-
tunities now exist to initiate such an approach.
The new general practitioner contract has resulted
in the establishment of many patients’ registers, such as
those for chronic obstructive pulmonary disease,
ischaemic heart disease, and cardiac failure.8 Practices
are now reimbursed for doing regular assessments and
investigations, offering regular opportunities to iden-
tify those who may be entering the last months of life.
When establishing these registers and reviewing those
on them clinicians should routinely ask the question of
anticipated prognosis.
Community nurses are playing a larger part in car-
ing for people with chronic illnesses. Practice nurses
reviewing people annually, district nurses caring for
housebound patients, and health visitors proactively
visiting the elderly could all periodically ask themselves
this question as a trigger to adopting a holistic
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palliative care approach. Palliative care in the commu-
nity can thus become more extensive and proactive.9
How might patients and professionals feel about a
more proactive approach to palliative care? The accept-
ance of palliation requires a joint signing up by
professionals, the patient, the family, or other carers.
Early recognition is necessary, but not sufficient, for
effective care. Most people with progressive chronic
illnesses have already brushed with death and have
competing narratives in their minds. On the one hand
they hope that their condition will not deteriorate, and
on the other they acknowledge that death is inevitable.1
Greater awareness of these conflicting narratives should
make it easier for professionals to combine active treat-
ment and a supportive approach. People with disabling,
progressive illnesses expect active care, but they also
seek comfort, control, and dignity. The barriers to effec-
tive communication about emotional and end of life
issues are well recognised. Doctors’ concerns include
causing distress, damaging hope, and having time for
such discussions. Patients and families have equal prob-
lems.10 An individual approach to sharing information
in the context of a good professional-patient relation-
ship is key.11 Some opening questions that might help
professionals start to explore these issues with patients
who wish to do so are given in the box.
Estimating prognosis is an inexact science,12 but
prognostic uncertainty should not prevent us talking
with our patients about this issue, as a noteworthy
number will die suddenly. We must not inadvertently
fall into the trap of prognostic paralysis. So when we
are next monitoring prognostic indicators and observe
an irreversible decline, why not simply ask ourselves:
“Would I be surprised if my patient were to die in the
next 12 months?” And if the answer is no, we need to
give the patient and his or her family an opportunity to
plan for a good death, instead of just monitoring a
downward set of physical variables until death.
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Nurses as leaders in chronic care
Their role is pivotal in improving care for chronic diseases
The chronic care model is widely accepted as astandard for improving care for people withchronic conditions.1 In the United States, pro-
jects to put the chronic care model into practice often
centre around doctors. Yet the healthcare literature and
the experience of many efforts to improve chronic care
indicate that nurses, not doctors, are the key to imple-
menting the chronic care model in a patient centred
care team. By nature of their education and role, nurses
are in a position to champion transformation of chronic
care. In many nations, but not in the United States,
nurses have been taking this central role for decades.w1
The essence of the chronic care model is the interac-
tion between an informed, activated patient and a
prepared, proactive practice team.w2 Indeed, such a team
is nearly always needed to enable patients to become
adequately informed and activated.What is the record of
doctors in informing and activating patients?
A study of family physicians in the United States
found that patients making an initial statement of their
problem were interrupted by the doctor after an aver-
age of 23 seconds.2 Half of patients finish an office visit
not understanding what they were told by the doctor.3
The commonest reason for patients not taking their
medicines as prescribed is poor communication from
doctor to patient.w3 In a study of treatment decisions in
over 1000 audiotaped outpatient visits to doctors, the
patient was not involved in the decisions 91% of the
time.4 Poorly informed passive patients are less likely to
Adopting patient centred supportive care: possible questions
• What’s the most important issue in your life right now?
• What helps you keep going?
• How do you see the future?
• What is your greatest worry or concern?
• Are there ever times when you feel down?
• If things got worse, where would you like to be cared for?
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